Morgan Stanley
GDRX icon

Morgan Stanley’s GoodRx Holdings GDRX Stock Holding History

Morgan Stanley’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
36,861
-293,430
-89% -$746K ﹤0.01% 6227
2026
Q1 		$647K Sell
330,291
-788,136
-70% -$1.85M ﹤0.01% 5353
2025
Q4 		$3.03M Buy
1,118,427
+729,181
+187% +$2.39M ﹤0.01% 4532
2025
Q3 		$1.65M Sell
389,246
-43,033
-10% -$189K ﹤0.01% 4900
2025
Q2 		$2.15M Sell
432,279
-297,761
-41% -$1.29M ﹤0.01% 4654
2025
Q1 		$3.22M Buy
730,040
+399,975
+121% +$1.88M ﹤0.01% 4280
2024
Q4 		$1.53M Sell
330,065
-62,182
-16% -$342K ﹤0.01% 4873
2024
Q3 		$2.72M Sell
392,247
-629,553
-62% -$4.94M ﹤0.01% 4436
2024
Q2 		$7.97M Sell
1,021,800
-484,786
-32% -$3.59M ﹤0.01% 3493
2024
Q1 		$10.7M Sell
1,506,586
-758,633
-33% -$5.02M ﹤0.01% 3297
2023
Q4 		$15.2M Buy
2,265,219
+522,560
+30% +$2.94M ﹤0.01% 2963
2023
Q3 		$9.81M Buy
1,742,659
+302,177
+21% +$2.01M ﹤0.01% 3146
2023
Q2 		$7.95M Sell
1,440,482
-99,901
-6% -$538K ﹤0.01% 3384
2023
Q1 		$9.63M Buy
1,540,383
+227,079
+17% +$1.27M ﹤0.01% 3182
2022
Q4 		$6.12M Buy
1,313,304
+27,908
+2% +$137K ﹤0.01% 3567
2022
Q3 		$6M Sell
1,285,396
-17,572,096
-93% -$111M ﹤0.01% 3522
2022
Q2 		$112M Buy
18,857,492
+281,300
+2% +$3.13M 0.01% 858
2022
Q1 		$359M Buy
18,576,192
+5,687,080
+44% +$130M 0.05% 355
2021
Q4 		$421M Buy
12,889,112
+8,184,111
+174% +$329M 0.05% 332
2021
Q3 		$193M Buy
4,705,001
+639,551
+16% +$23.2M 0.03% 542
2021
Q2 		$146M Buy
4,065,450
+504,944
+14% +$18.6M 0.02% 657
2021
Q1 		$139M Buy
3,560,506
+855,772
+32% +$38.5M 0.02% 623
2020
Q4 		$109M Buy
2,704,734
+1,054,662
+64% +$48.5M 0.02% 684
2020
Q3 		$91.7M Buy
+1,650,072
New +$87.4M 0.02% 622

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley's GDRX Position: Q2 2026 in Review

Morgan Stanley reduced its GoodRx Holdings (GDRX) stake by 89% in Q2 2026, selling an estimated $746K and leaving 36,861 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #6227.

Morgan Stanley first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $421M in Q4 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Morgan Stanley held 36,861 shares of GoodRx Holdings worth $106K as of Q2 2026.
  • Morgan Stanley sold 293,430 GoodRx Holdings shares in Q2 2026, an estimated $746K.
  • GoodRx Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6227 holding.
  • Morgan Stanley first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's GoodRx Holdings position peaked at $421M in Q4 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.